Are you looking to improve your understanding of how your antibodies bind, and how and where glycosylation is taking place?
Dr Jeroen Lammerts van Bueren a Senior Scientist at GenMab recently presented data suggesting where therapeutic mAbs are glycosylated and also what the effect of producing in rodent cell lines is in terms of binding:
Investigating the binding of IgE anti-gal-1.3 alpha-gal antibodies from allergic patients to a panel of therapeutic antibodies
- Non-human a-Gal glycan structures on therapeutic antibodies.
- The interaction between IgE against a-Gal and antibody therapeutics
- Underlying mechanisms
Click here for the full presentation
Do you want to find out more?